TY - CHAP PY - 2008 DA - 2008// TI - Panel on Clinical Practices for the Treatment of HIV Infection: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents BT - Department of Health and Human Services and Henry J. Kaiser Foundation ID - ref1 ER - TY - JOUR AU - Staszewski, S. AU - Keiser, P. AU - Montaner, J. AU - Raffi, F. AU - Gathe, J. AU - Brotas, V. AU - Hicks, C. AU - Hammer, S. M. AU - Cooper, D. AU - Johnson, M. AU - Tortell, S. AU - Cutrell, A. AU - Thorborn, D. AU - Isaacs, R. AU - Hetherington, S. AU - Steel, H. AU - Spreen, W. PY - 2001 DA - 2001// TI - CNAAB3005 International Study Team. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.9.1155 DO - 10.1001/jama.285.9.1155 ID - Staszewski2001 ER - TY - JOUR AU - Vibhagool, A. AU - Capn, P. AU - Schechter, M. AU - Smaill, F. AU - Soto-Ramirez, L. AU - Carosi, G. AU - Montroni, M. AU - Pharo, C. E. AU - Jordan, J. C. AU - Thomas, N. E. AU - Pearce, G. PY - 2004 DA - 2004// TI - Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naive adults: results of a 48-week open-label, equivalence trial (CNA3014) JO - Curr Med Res Opin VL - 20 UR - https://doi.org/10.1185/030079904125004006 DO - 10.1185/030079904125004006 ID - Vibhagool2004 ER - TY - JOUR AU - Kumar, P. N. AU - Rodriguez-French, A. AU - Thompson, M. A. AU - Tashima, K. T. AU - Averitt, D. AU - Wannamaker, P. G. AU - Williams, V. C. AU - Shaefer, M. S. AU - Pakes, G. E. AU - Pappa, K. A. PY - 2006 DA - 2006// TI - A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity JO - HIV Med VL - 7 UR - https://doi.org/10.1111/j.1468-1293.2006.00346.x DO - 10.1111/j.1468-1293.2006.00346.x ID - Kumar2006 ER - TY - JOUR AU - Gulick, R. M. AU - Ribaudo, H. J. AU - Shikuma, C. M. AU - Lustgarten, S. AU - Squires, K. E. AU - Meyer, W. A. AU - Acosta, E. P. AU - Schackman, B. R. AU - Pilcher, C. D. AU - Murphy, R. L. AU - Maher, W. E. AU - Witt, M. D. AU - Reichman, R. C. AU - Snyder, S. AU - Klingman, K. L. AU - Kuritzkes, D. R. PY - 2004 DA - 2004// TI - Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa031772 DO - 10.1056/NEJMoa031772 ID - Gulick2004 ER - TY - CHAP PY - 2008 DA - 2008// TI - Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents BT - Department of Health and Human Services ID - ref6 ER - TY - CHAP AU - Malan, N. AU - Krantz, E. AU - David, N. PY - 2006 DA - 2006// TI - Efficacy and safety of atazanavir-based therapy in antiretroviral naïve HIV-1 infected subjects, both with and without ritonavir: 48-week results from AI424-089 [Abstract 79] BT - 13th Conference on Retroviruses and Opportunistic Infections; Denver, CO, USA ID - Malan2006 ER - TY - STD TI - Reyataz® (atazanavir sulfate) [Product information]. Princeton, NJ: Bristol-Myers Squibb Company: 2007. ID - ref8 ER - TY - CHAP PY - 1992 DA - 1992// BT - Division of AIDS table forgrading severity of adult adverse experiences PB - NationalInstitute of Allergy and Infectious Diseases CY - NewYork ID - ref9 ER - TY - JOUR AU - Hirsch, M. S. AU - Brun-Vezinet, F. AU - Clotet, B. AU - Conway, B. AU - Kuritzkes, D. R. AU - D'Aquila, R. T. AU - Demeter, L. M. AU - Hammer, S. M. AU - Johnson, V. A. AU - Loveday, C. AU - Mellors, J. W. AU - Jacobsen, D. M. AU - Richman, D. D. PY - 2003 DA - 2003// TI - Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel JO - Clin Infect Dis VL - 37 UR - https://doi.org/10.1086/375597 DO - 10.1086/375597 ID - Hirsch2003 ER - TY - JOUR AU - Grundy, S. M. AU - Cleeman, J. I. AU - Merz, C. N. AU - Brewer, H. B. AU - Clark, L. T. AU - Hunninghake, D. B. AU - Pasternak, R. C. AU - Smith, S. C. AU - Stone, N. J. PY - 2004 DA - 2004// TI - Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines JO - Circulation VL - 110 UR - https://doi.org/10.1161/01.CIR.0000133317.49796.0E DO - 10.1161/01.CIR.0000133317.49796.0E ID - Grundy2004 ER - TY - JOUR PY - 2001 DA - 2001// TI - Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.19.2486 DO - 10.1001/jama.285.19.2486 ID - ref12 ER - TY - JOUR AU - Sanne, I. AU - Piliero, P. AU - Squires, K. AU - Thiry, A. AU - Schnittman, S. PY - 2003 DA - 2003// TI - Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naïve subjects JO - J Acquir Immune Defic Syndr VL - 32 UR - https://doi.org/10.1097/00126334-200301010-00004 DO - 10.1097/00126334-200301010-00004 ID - Sanne2003 ER - TY - JOUR AU - Dube, M. P. AU - Stein, J. H. AU - Aberg, J. A. AU - Fichtenbaum, C. J. AU - Gerber, J. G. AU - Tashima, K. T. AU - Henry, W. K. AU - Currier, J. S. AU - Sprecher, D. AU - Glesby, M. J. PY - 2003 DA - 2003// TI - Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group JO - Clin Infect Dis VL - 37 UR - https://doi.org/10.1086/378131 DO - 10.1086/378131 ID - Dube2003 ER - TY - CHAP AU - Sutherland-Phillips, D. H. AU - Hernandez, J. E. AU - Wannamaker, P. G. AU - Dix, L. P. AU - Shaefer, M. S. PY - 2006 DA - 2006// TI - Differential effects of nucleoside reverse transcriptase inhibitors (NRTI) with and without a protease inhibitor (PI) or non-nucleoside reverse transcriptase inhibitor (NNRTI) on lipid parameters [Abstract 69] BT - 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, San Francisco, CA, USA ID - Sutherland-Phillips2006 ER - TY - JOUR AU - Shikuma, C. M. AU - Yang, Y. AU - Glesby, M. J. PY - 2007 DA - 2007// TI - Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 infection (AIDS Clinical Trials Group Study A5095) JO - J Acquir Immune Defic Syndr VL - 44 UR - https://doi.org/10.1097/QAI.0b013e318031d5a0 DO - 10.1097/QAI.0b013e318031d5a0 ID - Shikuma2007 ER -